| id | C00004635 |
|---|---|
| Name | Isorhamnetin / 3'-O-Methylquercetin / 3,4',5,7-Tetrahydroxy-3'-methoxyflavone / 3,5,7-Trihydroxy-2-(4-hydroxy-3-methoxyphenyl)-4H-1-benzopyran-4-one |
| CAS RN | 480-19-3 |
| Standard InChI | InChI=1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3 |
| Standard InChI (Main Layer) | InChI=1S/C16H12O7/c1-22-11-4-7(2-3-9(11)18)16-15(21)14(20)13-10(19)5-8(17)6-12(13)23-16/h2-6,17-19,21H,1H3 |
| Phytochemical cluster | No. 15 |
|---|---|
| KCF-S cluster | No. 3 |
| By standard InChI | CHEMBL379064 |
|---|---|
| By standard InChI Main Layer | CHEMBL379064 |
| By LinkDB | C10084 |
|---|
| By CAS RN | C047368 |
|---|
| class name | count |
|---|---|
| rosids | 47 |
| asterids | 22 |
| eudicotyledons | 6 |
| Spermatophyta | 4 |
| Liliopsida | 3 |
| family name | count |
|---|---|
| Fabaceae | 37 |
| Asteraceae | 17 |
| Taxaceae | 2 |
| Myrtaceae | 2 |
| Viscaceae | 2 |
| Lamiaceae | 1 |
| Rhamnaceae | 1 |
| Cistaceae | 1 |
| Velloziaceae | 1 |
| Nyctaginaceae | 1 |
| accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
|---|---|---|---|---|---|
| P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | CHEMBL379064 |
CHEMBL905752
(1)
|
0 / 0 |
| P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | CHEMBL379064 |
CHEMBL1023248
(1)
|
1 / 1 |
| P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | CHEMBL379064 |
CHEMBL1225717
(1)
|
0 / 0 |
| P04792 | Heat shock protein beta-1 | Unclassified protein | CHEMBL379064 |
CHEMBL993710
(1)
|
2 / 1 |
| P39748 | Flap endonuclease 1 | Enzyme | CHEMBL379064 |
CHEMBL1794486
(1)
|
0 / 0 |
| Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | CHEMBL379064 |
CHEMBL1225718
(1)
|
4 / 4 |
| P04745 | Alpha-amylase 1 | Enzyme | CHEMBL379064 |
CHEMBL964479
(2)
|
0 / 0 |
| P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL379064 |
CHEMBL1225716
(1)
|
0 / 0 |
| P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL379064 |
CHEMBL1614211
(2)
|
0 / 0 |
| Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL379064 |
CHEMBL1794536
(1)
|
0 / 0 |
| O00255 | Menin | Unclassified protein | CHEMBL379064 |
CHEMBL1614257
(2)
CHEMBL1614531
(1)
|
2 / 5 |
| Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL379064 |
CHEMBL1614257
(2)
CHEMBL1614531
(1)
|
1 / 3 |
| compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
|---|---|---|---|---|---|---|---|
| C047368 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | ABCB1 protein results in increased transport of 3-methylquercetin |
increases transport
|
protein |
15969930
|
| C047368 | 4363 |
ABCC1
ABC29 ABCC GS-X MRP MRP1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 | 3-methylquercetin results in decreased activity of ABCC1 protein |
decreases activity
|
protein |
15670588
|
| C047368 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | 3-methylquercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of AHR protein] |
decreases reaction
/ increases activity |
protein |
19794518
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | 3-methylquercetin inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] |
decreases reaction
/ increases activity |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin] affects the activity of CYP1A1 protein |
affects activity
/ affects cotreatment |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] affects the activity of CYP1A1 protein |
affects activity
/ affects cotreatment |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] |
affects cotreatment
/ decreases reaction / increases activity |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
affects cotreatment
/ decreases reaction / increases activity |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin] inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] |
affects cotreatment
/ decreases reaction / increases activity |
protein |
21329749
|
| C047368 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] |
affects cotreatment
/ decreases reaction / increases activity |
protein |
21329749
|
| C047368 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | 3-methylquercetin results in decreased expression of CYP1B1 mRNA |
decreases expression
|
mRNA |
19794518
|
| C047368 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | 3-methylquercetin binds to ESR1 protein |
affects binding
|
protein |
14706564
|
| C047368 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | 3-methylquercetin binds to ESR2 protein |
affects binding
|
protein |
14706564
|
| C047368 | 4846 |
NOS3
ECNOS eNOS |
nitric oxide synthase 3 (endothelial cell) (EC:1.14.13.39) | 3-methylquercetin inhibits the reaction [Lipids results in decreased expression of NOS3] |
decreases expression
/ decreases reaction |
16891912
|
|
| C047368 | 4973 |
OLR1
CLEC8A LOX1 LOXIN SCARE1 SLOX1 |
oxidized low density lipoprotein (lectin-like) receptor 1 | 3-methylquercetin inhibits the reaction [Lipids results in increased expression of OLR1] |
decreases reaction
/ increases expression |
16891912
|
|
| C047368 | 7031 |
TFF1
BCEI D21S21 HP1.A HPS2 pNR-2 pS2 |
trefoil factor 1 | 3-methylquercetin results in increased expression of TFF1 mRNA |
increases expression
|
mRNA |
14706564
|
| OMIM | preferred title | UniProt |
|---|---|---|
| #606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
| #137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
| #231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
| #137760 | Glaucoma, primary open angle; poag |
Q16678
|
| #605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
| #145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
| #131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
| #608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
| #604229 | Peters anomaly |
Q16678
|
| #278300 | Xanthinuria, type i |
P47989
|
| KEGG | disease name | UniProt |
|---|---|---|
| H00033 | Adrenal carcinoma |
O00255
(related)
|
| H00034 | Carcinoid |
O00255
(related)
|
| H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
| H00246 | Primary hyperparathyroidism |
O00255
(related)
|
| H01102 | Pituitary adenomas |
O00255
(related)
|
| H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
| H00192 | Xanthinuria |
P47989
(related)
|
| H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
| H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
| H00612 | Primary open angle glaucoma |
Q16678
(related)
|
| H01075 | Peters anomaly |
Q16678
(related)
|
| H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
| H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|